Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Degenerative Diseases, Central Nervous System

1-methyl-3-isobutylxanthine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Eftekhari, E1
Ghollasi, M1
Halabian, R1
Soltanyzadeh, M1
Enderami, SE1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Degenerative Diseases, Central Nervous System

ArticleYear
Nisin and non-essential amino acids: new perspective in differentiation of neural progenitors from human-induced pluripotent stem cells in vitro.
    Human cell, 2021, Volume: 34, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; Amino Acids; Cell Differentiation; Cell- and Tissue-Based Therapy; Cell

2021